The so-called ''placebo effect'' in benign prostatic hyperplasia treatment trials represents partially a conditional regression to the mean induced by censoring

Author： Sech S.M.   Montoya J.D.   Bernier P.A.   Barnboym E.   Brown S.   Gregory A.   Roehrborn C.G.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.51, Iss.2, 1998-02, pp. : 242-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia

By Hillman A.L.   Schwartz J.S.   Willian M.K.   Peskin E.   Roehrborn C.G.   Oesterling J.E.   Mason M.F.   Maurath C.J.   Deverka P.A.   Padley R.J.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 169-178

Elsevier

Access to resources Recommend Favorite

Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia

By Boyle P.   Robertson C.   Manski R.   Padley R.J.   Roehrborn C.G.  

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 717-722

Elsevier

Access to resources Recommend Favorite

Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia

By Boyle P.   Robertson C.   Lowe F.   Roehrborn C.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 533-539

Elsevier

Access to resources Recommend Favorite

Laser treatment of benign prostatic hyperplasia

By Kuntz Rainer  

World Journal of Urology, Vol. 25, Iss. 3, 2007-06 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite

Lasers in the treatment of benign prostatic hyperplasia

By Gerber G.S.  

Urology, Vol. 45, Iss. 2, 1995-02 ,pp. : 193-199

Elsevier

Access to resources Recommend Favorite